Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Bold Ventures Signs Agreement to Acquire 6 Key Claims Contiguous to its Joutel Property, Quebec March 1, 2026 Tech Weekly: Stocks See Minor Reprieve Before Ending Week in the Red February 28, 2026 UK Enters Commercial Lithium Production with Geothermal Plant Launch February 27, 2026
Bold Ventures Signs Agreement to Acquire 6 Key Claims Contiguous to its Joutel Property, Quebec March 1, 2026